Erlotinib Versus Oral Etoposide in Patients With Recurrent or Refractory Pediatric Ependymoma
Clinical trial NCT01032070 · TERMINATED
Trial details
- NCT number
- NCT01032070
- Sponsor
- OSI Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-27
- Primary completion
- 2012-11-26
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.